3-Bromotyrosine

Two people can carry the same number of allergy cells in their blood and have very different amounts of damage in their airways. What separates them isn't how many of these cells they have. It's how hard those cells have been working.

This urine test picks up a chemical trail those cells leave behind. When they fire, they release a bleach-like chemical that permanently marks nearby proteins, and a fragment of that mark ends up in your urine. Measuring it gives a research-grade read on whether allergy-driven inflammation has been active, not just present.

What This Marker Measures

3-bromotyrosine is a changed form of tyrosine. Tyrosine is one of the building blocks used to make proteins. The change happens when an eosinophil is activated. Eosinophils are white blood cells involved in allergic airway inflammation and many, but not all, asthma patterns.

When eosinophils activate, they release eosinophil peroxidase. An enzyme is a protein that drives a chemical reaction. This one uses hydrogen peroxide and bromide from blood to make hypobromous acid, a highly reactive chemical. Hypobromous acid adds bromine to tyrosine in nearby proteins. 3-bromotyrosine is the mark left by that reaction.

This gives the marker a narrow target. A related marker, 3-chlorotyrosine, is made mainly through myeloperoxidase, an enzyme used by neutrophils and monocytes. Asthma studies that measured both markers generally found bromotyrosine tracking eosinophil peroxidase activity, while chlorotyrosine tracked different immune-cell chemistry. So a higher urinary 3-bromotyrosine result points more toward eosinophil activity than toward inflammation in general.

This is still a research-grade marker. There is no universally agreed normal range, it is not part of routine asthma guidelines, and lab methods differ. The human evidence is mostly in asthma and allergic airway disease. A single number matters less than the pattern: how your result compares with your own prior results and with companion markers.

Asthma and Eosinophilic Airway Inflammation

In an early human study, people with asthma had roughly double the urinary 3-bromotyrosine of healthy people, though the exact values are hard to pin down and vary by lab method. Other work backs the link. When researchers placed an allergen directly into a small segment of asthmatic lung, the local level rose more than tenfold. In sputum from stable asthmatics, the marker tracked closely with eosinophil peroxidase itself, a strong correlation of about 0.79, where 1.0 would be a perfect match.

Sources: Mita et al. 2004; Wu et al. 2000; Aldridge et al. 2002; Wedes et al. 2009; Wedes et al. 2011; Wang et al. 2022.

What this means for you: a higher result is a research signal that eosinophil-driven inflammation has been active in your airways. That is the process many asthma controller treatments aim to quiet. It is a reason to look closer, not a diagnosis on its own.

Where It Falls Short: Telling Asthma Types Apart

The marker can flag eosinophil activity, but it is poor at sorting asthma subtypes. In a study of more than 500 people, urinary 3-bromotyrosine was elevated in both aspirin-exacerbated respiratory disease and aspirin-tolerant asthma, but it did not separate the two. When added to two other markers, blood eosinophils and urinary leukotriene E4, it contributed nothing extra to predicting the aspirin-sensitive form.

When researchers tried to use a single research cutoff to classify asthma, the signal was specific but not sensitive. A high result carried more information than a low result. A low result did not rule out asthma.

The Aspirin Challenge Puzzle

When aspirin-sensitive asthmatics were given aspirin through a vein, urinary leukotriene E4 shot up. Urinary 3-bromotyrosine did not. That looks contradictory only if you expect every asthma trigger to light up every marker. It doesn't. Leukotriene E4 reflects a fast chemical-signal pathway involving several airway immune cells. Bromotyrosine reflects the accumulated work of eosinophils. Aspirin set off the first without acutely revving the second.

A Link to Airflow Narrowing

Eosinophil brominating activity does more than mark inflammation. In blood samples, a related but different measurement from this urine test, higher systemic bromotyrosine came with lower activity of superoxide dismutase. Superoxide dismutase is one of the body's enzymes for neutralizing reactive oxygen chemicals. The link was moderate, and lower activity tracked with worse airflow obstruction. Whether urinary 3-bromotyrosine predicts that decline on its own has not been shown.

Why One Reading Isn't Enough

Because there is no fixed line to cross, your own trajectory is the reference point that matters. A single value tells you little without something to compare it to. A baseline plus a follow-up can show whether the biology is quieting, persisting, or rising while symptoms lag behind.

When a Reading Can Mislead

• Kidney function and urine concentration: the result is often adjusted to creatinine, so abnormal kidney function or a very dilute or concentrated urine sample can distort the ratio without any change in eosinophil activity.
• The wrong cell type: a low result doesn't rule out neutrophil-driven inflammation, which shows up better on the chloro marker than on this one.
• Different urine fractions: older studies often measured free urinary bromotyrosine, while newer studies sometimes measure total conjugated bromotyrosine. Related, not interchangeable.
• Acute triggers: some triggers, like aspirin in sensitive people, drive other inflammation pathways without moving this marker right away.
• Assay differences: labs use different methods and reporting units. Compare results within the same lab over time rather than across labs.